Nu Skin Q3 revenue falls 14.6% to $311.0 million, and the company posts a net loss
Nu Skin reported third-quarter 2026 revenue of $311.0 million, down 14.6% from $364.2 million a year earlier, and a GAAP net loss of $0.7 million, or $(0.02) per diluted share, compared with net income of $17.1 million, or $0.34 per share. Excluding certain charges, third-quarter EPS was $0.10, and the company projects 2026 GAAP EPS of $(5.08) to $(4.98) on revenue of $1.26 billion to $1.29 billion, with the GAAP loss reflecting a $167.5 million valuation allowance on deferred tax assets.
Key points
- Q3 2026 revenue was $311.0 million, down 14.6%, with an approximately 1.1% foreign-currency impact; the company said revenue came in within its guidance range.
- Q3 GAAP operating margin was 1.6%, or 3.7% excluding certain charges, compared with 5.9% a year earlier.
- Nine-month 2026 net loss was $248.7 million, or $(5.13) per diluted share, versus net income of $145.7 million a year earlier.
- Q4 2026 revenue is projected at $310 million to $340 million, with GAAP EPS of $0.05 to $0.15; the company expects sequential growth in the fourth quarter.
The filing
Written by AI on Nov 9, 2026, 8:29 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 05, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.